Clincosm LogoSign in Get a demo

Epidemiology of Schizophrenia in Bulgaria

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00984373
Collaborator
(none)
440
Enrollment
7
Locations
2
Duration (Months)
62.9
Patients Per Site
31.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of:

  • Patient characteristics.

  • Diagnostic and treatment approaches: initial and subsequent.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    440 participants
    Time Perspective:
    Prospective
    Official Title:
    Epidemiological Study to Describe Approaches in Diagnosis, Treatment and Social Functioning of Schizophrenic Patients in Bulgaria
    Study Start Date :
    Sep 1, 2009
    Actual Primary Completion Date :
    Nov 1, 2009
    Actual Study Completion Date :
    Nov 1, 2009

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:

      • Patients with schizophrenia

      • Above 18 years

      • Signed Informed consent

      Exclusion Criteria:

      • Below 18 years

      • Consent refused

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Research Site Burgas Bulgaria
      2 Research Site Pazardzhik Bulgaria
      3 Research Site Sofia Bulgaria
      4 Research Site Stara Zagora Bulgaria
      5 Research Site Varna Bulgaria
      6 Research Site Veliko Tarnovo Bulgaria
      7 Research Site Vidin Bulgaria

      Sponsors and Collaborators

      • AstraZeneca

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00984373
      Other Study ID Numbers:
      • NIS-NBG-SER-2009/1
      First Posted:
      Sep 25, 2009
      Last Update Posted:
      Feb 4, 2010
      Last Verified:
      Feb 1, 2010
      Keywords provided by , ,
      Schizophrenia epidemiology
      Schizophrenic patients' social and health characteristics
      Additional relevant MeSH terms:
      Schizophrenia

      Study Results

      No Results Posted as of Feb 4, 2010